Leiming Wang

482 total citations
14 papers, 372 citations indexed

About

Leiming Wang is a scholar working on Molecular Biology, Cancer Research and Infectious Diseases. According to data from OpenAlex, Leiming Wang has authored 14 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Cancer Research and 1 paper in Infectious Diseases. Recurrent topics in Leiming Wang's work include Ubiquitin and proteasome pathways (4 papers), Cancer-related molecular mechanisms research (4 papers) and RNA modifications and cancer (3 papers). Leiming Wang is often cited by papers focused on Ubiquitin and proteasome pathways (4 papers), Cancer-related molecular mechanisms research (4 papers) and RNA modifications and cancer (3 papers). Leiming Wang collaborates with scholars based in China and United States. Leiming Wang's co-authors include Bo Liu, Jin Zhang, Minru Liao, Guan Wang, Liang Ouyang, Jie Liu, Sophia Y. Tsai, Mafei Xu, Ming‐Jer Tsai and Shulin Li and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Medicinal Chemistry and Protein Science.

In The Last Decade

Leiming Wang

14 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leiming Wang China 11 274 120 61 57 29 14 372
Yang-ling Li China 11 229 0.8× 102 0.8× 82 1.3× 77 1.4× 42 1.4× 22 350
Gaoyang Zhu China 9 323 1.2× 95 0.8× 115 1.9× 46 0.8× 40 1.4× 14 486
Fuyan Xu China 7 241 0.9× 101 0.8× 50 0.8× 87 1.5× 34 1.2× 12 364
Yu Hyun Jeon South Korea 13 389 1.4× 104 0.9× 117 1.9× 37 0.6× 32 1.1× 17 478
Irene Marchesi Italy 14 315 1.1× 85 0.7× 107 1.8× 74 1.3× 46 1.6× 23 452
Kyung‐Min Yang South Korea 12 284 1.0× 68 0.6× 66 1.1× 47 0.8× 21 0.7× 22 413
Peipei Nie China 8 277 1.0× 163 1.4× 71 1.2× 35 0.6× 19 0.7× 8 400
Jung Yoo South Korea 14 400 1.5× 107 0.9× 122 2.0× 38 0.7× 28 1.0× 19 529
Yujiao Zou China 8 374 1.4× 178 1.5× 92 1.5× 39 0.7× 14 0.5× 10 488
Joanna Kałafut Poland 11 329 1.2× 110 0.9× 109 1.8× 30 0.5× 44 1.5× 27 498

Countries citing papers authored by Leiming Wang

Since Specialization
Citations

This map shows the geographic impact of Leiming Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leiming Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leiming Wang more than expected).

Fields of papers citing papers by Leiming Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leiming Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leiming Wang. The network helps show where Leiming Wang may publish in the future.

Co-authorship network of co-authors of Leiming Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Leiming Wang. A scholar is included among the top collaborators of Leiming Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leiming Wang. Leiming Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Pan, Yanchao, Qing Xiang, Kai Deng, et al.. (2025). Engineering IGF2 for Lysosome‐targeting chimeras development to target drug‐resistant membrane proteins in tumor therapy. Protein Science. 34(3). e70051–e70051. 2 indexed citations
2.
Kang, Diana D., Xucheng Hou, Leiming Wang, et al.. (2024). Engineering LNPs with polysarcosine lipids for mRNA delivery. Bioactive Materials. 37. 86–93. 36 indexed citations
3.
Wang, Leiming, et al.. (2023). H3K27 acetylation activated‐CD109 evokes 5‐fluorouracil resistance in gastric cancer via the JNK/MAPK signaling pathway. Environmental Toxicology. 38(12). 2857–2866. 1 indexed citations
4.
5.
6.
Zhu, Xuewei, Li Liu, Yang Wang, et al.. (2021). lncRNA MIAT/HMGB1 Axis Is Involved in Cisplatin Resistance via Regulating IL6-Mediated Activation of the JAK2/STAT3 Pathway in Nasopharyngeal Carcinoma. Frontiers in Oncology. 11. 651693–651693. 20 indexed citations
7.
Li, Tao, Jie Yang, Ben Yang, et al.. (2021). Ketamine Inhibits Ovarian Cancer Cell Growth by Regulating the lncRNA-PVT1/EZH2/p57 Axis. Frontiers in Genetics. 11. 597467–597467. 46 indexed citations
8.
Wang, Leiming, et al.. (2021). Long noncoding RNA CRNDE functions as a diagnostic and prognostic biomarker in osteosarcoma, as well as promotes its progression via inhibition of miR‐335‐3p. Journal of Biochemical and Molecular Toxicology. 35(5). e22734–e22734. 20 indexed citations
9.
Liao, Minru, Jin Zhang, Guan Wang, et al.. (2021). Small-Molecule Drug Discovery in Triple Negative Breast Cancer: Current Situation and Future Directions. Journal of Medicinal Chemistry. 64(5). 2382–2418. 82 indexed citations
10.
11.
Fu, Leilei, Yi Liu, Kai Zhang, et al.. (2020). Discovery of a novel small-molecule inhibitor of Fam20C that induces apoptosis and inhibits migration in triple negative breast cancer. European Journal of Medicinal Chemistry. 210. 113088–113088. 23 indexed citations
12.
Wang, Leiming, et al.. (2019). Small molecule JQ1 promotes prostate cancer invasion via BET-independent inactivation of FOXA1. Journal of Clinical Investigation. 130(4). 1782–1792. 52 indexed citations
13.
14.
Yu, Wenjuan, Leiming Wang, Yuewei Wang, et al.. (2012). A novel tumor metastasis suppressor gene LASS2/TMSG1 interacts with vacuolar ATPase through its homeodomain. Journal of Cellular Biochemistry. 114(3). 570–583. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yang-ling Li Breakdown of academic impact, for papers by Gaoyang Zhu Breakdown of academic impact, for papers by Fuyan Xu Breakdown of academic impact, for papers by Yu Hyun Jeon Breakdown of academic impact, for papers by Irene Marchesi Breakdown of academic impact, for papers by Kyung‐Min Yang Breakdown of academic impact, for papers by Peipei Nie Breakdown of academic impact, for papers by Jung Yoo Breakdown of academic impact, for papers by Yujiao Zou Breakdown of academic impact, for papers by Joanna Kałafut
Rankless by CCL
2026